in respect of which the Incurrence Test is applied. The EBITDA shall be calculated as set out in paragraph (c) below.
(c)
The figures for the EBITDA, Finance Charges and Net Finance Charges for the
Relevant Period ending on the last day of the period covered by the most recent
36
Financial Report shall be used for the Incurrence Test, but adjusted so that:
(i) entities acquired or disposed of (or, in the event of any Restricted Disposal, assets or operations disposed of) by the Group during the Relevant Period, or after the end of the Relevant Period but before the relevant testing date, shall be included or excluded (as applicable), pro forma, for the entire Relevant Period;
(ii) any entity to be acquired with the proceeds from New Debt shall be included, pro forma, for the entire Relevant Period; and
(iii) the figure for EBITDA shall take into account reasonable cost synergies and cost savings to be achieved for the Group during the coming 12 months as a result of an acquisition referred to in paragraph (ii) above, provided that (A) such cost synergies and cost savings have been verified by an independent financial due diligence advisor, acceptable to the Bond Trustee, in relation to the acquisition and (B) the increase in EBITDA based on such adjustments shall in no event exceed 10% of the EBITDA for the Group (as measured following any adjustments pursuant to paragraphs (i) and (ii) above).
